- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01880710
Total Versus Subtotal Abdominal Hysterectomy
Randomized Clinical Trial of Total Versus Subtotal Abdominal Hysterectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study included women who were offered a hysterectomy for benign uterine disease such as: metrorrhagia, menorrhagia, fibroids, endometriosis,and pelvic pain. Women in need of hysterectomy for malignant disease or because of prolapse of the uterus were not included. They were followed up by a questionnaire covering all outcome measures as described above. Background information was registered in a second questionnaire prior to surgery. All gynaecological departments in Denmark were invited to join the trial. 11 departments contributed randomized patients to the trial.
the results up to 1 year after surgery have been published, links can be found in the citation list. The results from the 5 year follow up have not yet been published.
The questionnaire used in this trial consists of the validated SF-36 (Short Form 36) quality of life questionnaire as well as a thorough questionnaire regarding the outcome measures described elsewhere. The entire questionnaire was validated prior to the beginning of the trial.
A second questionnaire has been added in the 15 year follow up: PFDI-20(Pelvic Floor Distress Inventory 20). The investigators included this, as it is more thorough regarding pelvic organ prolapse and in particular a "bother" measure than the original questionnaire.
The 20 min. pad-weighing test has been tested against the 1 hour gold-standard used by the ICS (International Continence Society) and has been found to give comparable results.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Region Sjaelland
-
Nykoebing Falster, Region Sjaelland, Denmark, 4800
- Nykoebing Falster County Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-Women undergoing abdominal hysterectomy for benign uterine disease at a gynaecological department in Denmark (15 years ago)
Exclusion Criteria:
- malignant disease
- mental disease
- diabetes
- neurological disease
- not able to read and write Danish
- pelvic organ prolapse as the reason for hysterectomy
- prior surgery for urinary incontinence
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Total hysterectomy
removal of the entire uterus including the cervix.
open abdominal surgery.
No specific procedures were asked of the surgeon.
They were free to do the procedure the way they were used to doing it.
|
total abdominal hysterectomy where the body as well as the cervix of the uterus are removed.
|
|
Experimental: Subtotal Hysterectomy
removal of the uterine body only leaving the cervix in situ.
The surgeon was free to do the procedure as he was used to.
The only direction was that the cervical canal should be electrocoagulated.
|
Subtotal abdominal hysterectomy where the body of the uterus is removed but the cervix is spared.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in Urinary incontinence from baseline (preoperatively)
Time Frame: 2 months, 6months, 1, 5 and 15 years postoperatively
|
urinary incontinence measured by questionnaire filled out by the participants at each time point as well as a more objective measure: pad weighing test and voiding diary at 15 years
|
2 months, 6months, 1, 5 and 15 years postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pelvic organ prolapse
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
subjective measure by questionnaire at each time point as well as objective measure by POP-Q measurement at 15 years
|
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
|
cervical problems in the SAH group
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
questionnaire regarding bleeding at each time point, pap-smear regarding dysplasia at 15 years discharge summaries from hospital admissions/contacts regarding cervical problems.
|
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
|
voiding difficulties and LUTS (Lower Urinary Tract Symptoms)
Time Frame: preoperatively, 2 months, 6 months, 1, 5 and 15 years postoperatively
|
covered by the questionnaire at each time point regarding urinary tract infections and problems emptying the bladder.
In addition the 15 year follow up consists of uroflow, dip-stick for urinary infection as well as post-voiding ultrasound of the bladder to detect urinary retention.
|
preoperatively, 2 months, 6 months, 1, 5 and 15 years postoperatively
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
quality of life
Time Frame: preoperatively, 2 months, 6months, 1 and 15 years postoperatively
|
SF-36 questionnaire at each time point
|
preoperatively, 2 months, 6months, 1 and 15 years postoperatively
|
|
sexuality
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
questionnaire at each time point
|
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
|
pelvic pain
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
questionnaire at each time point
|
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
|
bowel problems
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
questionnaire at each time point
|
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
|
per- and postoperative complications
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
questionnaire at each time points and case records regarding related surgery (hernia, bowel obstruction, removal of the cervix, surgery for urinary incontinence and pelvic organ prolapse)looked up in the clinical registry
|
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lea L Andersen, MD, Nykoebing Falster County Hospital
- Study Director: Helga ME Gimbel, Dr.med.sci., University of Southern Denmark
Publications and helpful links
General Publications
- Gimbel H, Zobbe V, Ottesen BS, Tabor A. Randomized clinical trial of total vs. subtotal hysterectomy: validity of the trial questionnaire. Acta Obstet Gynecol Scand. 2002 Oct;81(10):968-74. doi: 10.1034/j.1600-0412.2002.811012.x.
- Gimbel H, Zobbe V, Andersen BJ, Sorensen HC, Toftager-Larsen K, Sidenius K, Moller N, Madsen EM, Vejtorp M, Clausen H, Rosgaard A, Villumsen J, Gluud C, Ottesen BS, Tabor A. Lower urinary tract symptoms after total and subtotal hysterectomy: results of a randomized controlled trial. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Jul-Aug;16(4):257-62. doi: 10.1007/s00192-005-1291-8.
- Gimbel H, Zobbe V, Andersen BM, Filtenborg T, Gluud C, Tabor A. Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results. BJOG. 2003 Dec;110(12):1088-98.
- Zobbe V, Gimbel H, Andersen BM, Filtenborg T, Jakobsen K, Sorensen HC, Toftager-Larsen K, Sidenius K, Moller N, Madsen EM, Vejtorp M, Clausen H, Rosgaard A, Gluud C, Ottesen BS, Tabor A. Sexuality after total vs. subtotal hysterectomy. Acta Obstet Gynecol Scand. 2004 Feb;83(2):191-6. doi: 10.1111/j.0001-6349.2004.00311.x.
- Andersen LL, Moller LM, Gimbel HM. Low adherence to cervical cancer screening after subtotal hysterectomy. Dan Med J. 2015 Dec;62(12):A5165.
- Andersen LL, Alling Moller LM, Gimbel HM. Objective comparison of subtotal vs. total abdominal hysterectomy regarding pelvic organ prolapse and urinary incontinence: a randomized controlled trial with 14-year follow-up. Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:40-5. doi: 10.1016/j.ejogrb.2015.06.033. Epub 2015 Jul 9.
- Andersen LL, Moller LM, Gimbel H; Danish Hysterectomy Trial Group. Lower urinary tract symptoms after subtotal versus total abdominal hysterectomy: exploratory analyses from a randomized clinical trial with a 14-year follow-up. Int Urogynecol J. 2015 Dec;26(12):1767-72. doi: 10.1007/s00192-015-2778-6. Epub 2015 Jul 28.
- Andersen LL, Zobbe V, Ottesen B, Gluud C, Tabor A, Gimbel H; Danish Hysterectomy Trial Group. Five-year follow up of a randomised controlled trial comparing subtotal with total abdominal hysterectomy. BJOG. 2015 May;122(6):851-857. doi: 10.1111/1471-0528.12914. Epub 2014 Jun 11.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- sj-268
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Benign Uterine Disease
-
St. Louis UniversityCompletedBenign Uterine DiseaseUnited States
-
Womens CareEthicon Endo-SurgeryCompleted
-
CHA UniversityCompletedBenign Uterine DiseaseKorea, Republic of
-
Cairo UniversityCompletedHysterectomy, Benign Uterine DiseasesEgypt
-
Cairo UniversityCompletedHysterectomy, Benign Uterine DiseasesEgypt
-
Asan Medical CenterAstellas Pharma IncUnknownBenign Uterine DiseaseKorea, Republic of
-
Hanyang University Seoul HospitalCompletedHysterectomy, Benign Uterine Diseases
-
University Hospital, Clermont-FerrandSTORZ® laboratoryUnknownBenign Uterine DiseasesFrance
-
Asan Medical CenterCompletedBenign or Preinvasive Uterine DiseaseKorea, Republic of
Clinical Trials on Total Hysterectomy
-
Queensland Centre for Gynaecological CancerNational Health and Medical Research Council, Australia; Johnson & Johnson... and other collaboratorsCompletedEndometrial CancerUnited Kingdom, Australia, Hong Kong, New Zealand
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingEndometriosis | Adenomyosis | Metrorrhagia | Fibroid Uterus | Abnormal Uterine Bleeding | Benign Gynecologic NeoplasmItaly
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...CompletedHysterectomyTurkey (Türkiye)
-
Obstetrics & Gynecology Hospital of Fudan UniversityShanghai Zhongshan Hospital; RenJi Hospital; Children's Hospital of Fudan University and other collaboratorsRecruiting
-
University of PalermoNot yet recruiting
-
Obstetrics & Gynecology Hospital of Fudan UniversityShanghai Zhongshan Hospital; RenJi Hospital; Children's Hospital of Fudan University and other collaboratorsRecruiting
-
Hua JiangShanghai Zhongshan Hospital; RenJi Hospital; Children's Hospital of Fudan University and other collaboratorsRecruiting
-
Queensland Centre for Gynaecological CancerM.D. Anderson Cancer CenterCompletedCervical CancerUnited States, China, Korea, Republic of, Australia, Canada, Italy, Argentina, Brazil, Bulgaria, Colombia, Mexico, Peru, Puerto Rico
-
South Valley UniversityCompletedProlapse GenitalEgypt
-
Turku University HospitalCompletedAbdominal Hysterectomy (& Wertheim)Finland